Walmsley S - Search Results

1

Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants.

Banerjee A, Lew J, Kroeker A, Baid K, Aftanas P, Nirmalarajah K, Maguire F, Kozak R, McDonald R, Lang A, Gerdts V, Straus SE, Gilbert L, Li AX, Mozafarihashjin M, Walmsley S, Gingras AC, Wrana JL, Mazzulli T, Colwill K, McGeer AJ, Mubareka S, Falzarano D. Banerjee A, et al. Among authors: walmsley s. Med. 2022 Jun 10;3(6):422-432.e3. doi: 10.1016/j.medj.2022.04.002. Epub 2022 Apr 14. Med. 2022. PMID: 35437520 Free PMC article.

2

Evaluation of the Digene Hybrid Capture System for detection and quantitation of human cytomegalovirus viremia in human immunodeficiency virus-infected patients.

Mazzulli T, Wood S, Chua R, Walmsley S. Mazzulli T, et al. Among authors: walmsley s. J Clin Microbiol. 1996 Dec;34(12):2959-62. doi: 10.1128/jcm.34.12.2959-2962.1996. J Clin Microbiol. 1996. PMID: 8940430 Free PMC article.

3

Long-term predictive value of a single cytomegalovirus (CMV) DNA PCR assay for CMV disease in human immunodeficiency virus-infected patients.

Walmsley S, Mazzulli T, Krajden M. Walmsley S, et al. J Clin Microbiol. 1998 Jan;36(1):281-3. doi: 10.1128/JCM.36.1.281-283.1998. J Clin Microbiol. 1998. PMID: 9431967 Free PMC article.

4

Predictive value of cytomegalovirus (CMV) antigenemia and digene hybrid capture DNA assays for CMV disease in human immunodeficiency virus-infected patients.

Walmsley S, O'Rourke K, Mortimer C, Rachlis A, Fong I, Mazzulli T. Walmsley S, et al. Clin Infect Dis. 1998 Sep;27(3):573-81. doi: 10.1086/514703. Clin Infect Dis. 1998. PMID: 9770159

5

Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients.

Humar A, Gregson D, Caliendo AM, McGeer A, Malkan G, Krajden M, Corey P, Greig P, Walmsley S, Levy G, Mazzulli T. Humar A, et al. Among authors: walmsley s. Transplantation. 1999 Nov 15;68(9):1305-11. doi: 10.1097/00007890-199911150-00015. Transplantation. 1999. PMID: 10573068

6

Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression.

Walmsley S, King S, McGeer A, Ye Y, Richardson S. Walmsley S, et al. Clin Infect Dis. 2001 Jun 1;32(11):1554-61. doi: 10.1086/320517. Epub 2001 May 4. Clin Infect Dis. 2001. PMID: 11340526

7

Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2.

Jamal AJ, Mozafarihashjin M, Coomes E, Powis J, Li AX, Paterson A, Anceva-Sami S, Barati S, Crowl G, Faheem A, Farooqi L, Khan S, Prost K, Poutanen S, Taylor M, Yip L, Zhong XZ, McGeer AJ, Mubareka S; Toronto Invasive Bacterial Diseases Network COVID-19 Investigators. Jamal AJ, et al. Clin Infect Dis. 2021 Mar 15;72(6):1064-1066. doi: 10.1093/cid/ciaa848. Clin Infect Dis. 2021. PMID: 32584972 Free PMC article.

8

Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trial.

Tan DHS, Chan AK, Jüni P, Tomlinson G, Daneman N, Walmsley S, Muller M, Fowler R, Murthy S, Press N, Cooper C, Lee T, Mazzulli T, McGeer A. Tan DHS, et al. Among authors: walmsley s. Trials. 2021 Mar 22;22(1):224. doi: 10.1186/s13063-021-05134-7. Trials. 2021. PMID: 33752741 Free PMC article.

9

Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination.

Walmsley S, Nabipoor M, Lovblom LE, Ravindran R, Colwill K, McGeer A, Dayam RM, Manase D, Gingras AC, On Behalf Of The STOPCoV Team. Walmsley S, et al. Vaccines (Basel). 2023 Dec 28;12(1):36. doi: 10.3390/vaccines12010036. Vaccines (Basel). 2023. PMID: 38250849 Free PMC article.

10

Declining Levels of Neutralizing Antibodies to SARS-CoV-2 Omicron Variants Are Enhanced by Hybrid Immunity and Original/Omicron Bivalent Vaccination.

Walmsley S, Nabipoor M, Qi F, Lovblom LE, Ravindran R, Colwill K, Dayam RM, Tursun TR, Silva A, Gingras AC, On Behalf Of The STOPCoV Team. Walmsley S, et al. Vaccines (Basel). 2024 May 22;12(6):564. doi: 10.3390/vaccines12060564. Vaccines (Basel). 2024. PMID: 38932293 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

623 results

Search Page

Filters